等待开盘 08-19 09:30:00 美东时间
+0.060
+5.61%
今日重点评级关注:Truist Securities:维持AbCellera Biologics"买入"评级,目标价从12美元升至30美元;Stifel:维持Proficient Auto Logistics"买入"评级,目标价从9美元升至12美元
08-12 08:45
Citigroup analyst Daniel Grosslight downgrades Accendra Health (NYSE:ACH) from Buy to Neutral and lowers the price target from $4.5 to $1.5.
08-11 20:21
Accendra Health ( ($ACH) ) has shared an announcement. On August 10, 2026, Acce...
08-10 18:56
Accendra Health (NYSE:ACH) lowers FY2026 sales outlook from $2.550 billion-$2.650 billion to $2.450 billion-$2.550 billion vs $2.574 billion estimate.
08-10 18:46
Accendra Health, Inc. (NYSE:ACH) (the Company) today announced that President and Chief Executive Officer Edward A. Pesicka has informed the Board of Directors of his plan to retire by the end of 2026, after more than seven years with the Company. Mr. Pesicka will also retire from the Company’s Boar...
08-10 18:36
Accendra Health 2026财年第二季度营收下降约10.1%至6.132亿美元,而GAAP持续经营业务摊薄每股亏损从1.09美元扩大至1.16美元。调整后EBITDA从9660万美元降至6010万美元,自由现金流转为负2510万美元。尽管因某大型商业支付方退出而进行了成本削减,但该季度毛利依然较低。Accendra Health还削减了3.85亿美元的债务,并更新了2026财年业绩指引,预计营收为24.5亿至25.5亿美元,调整后EBITDA为3亿至3.2亿美元。
08-10 10:56
Accendra Health (ACH) is scheduled to announce Q2 earnings results on Monday, August 10th, before market open. The consensus EPS Estimate is -$0.09 (-134.6% Y/Y) and the consensus Revenue Estimate is ...
08-07 23:49
今日重点评级关注:HC Wainwright & Co.:维持居里"买入"评级,目标价从17美元升至43美元;花旗:维持Klaviyo"买入"评级,目标价从31美元升至34美元
07-27 14:02
Citigroup analyst Daniel Grosslight maintains Accendra Health (NYSE:ACH) with a Buy and lowers the price target from $5 to $4.5.
07-25 03:18